Search clinical trials for: Levothyroxine Dosing

Total 1503 results

Bayer

Completed

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. (PACIFIC-AF)

Atrial Fibrillation (AF)

Spain, Belgium, Latvia, Italy, Switzerland, Canada, Austria, Japan, Czechia, Hungary, Netherlands, Sweden, France, United Kingdom
RWTH Aachen University
Clinical Evaluation Research Unit at Kingston General Hospital

Withdrawn

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial (EFFORTcombo)

Critical Illness | Malnutrition | Frailty | Sarcopenia | Nutritional Disorder

Germany
MetroHealth Medical Center

Completed

Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

Heartburn

United States
G. d'Annunzio University

Completed

Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration

Cardiovascular Diseases | Vesicle
Radboud University Medical Center
Erasmus Medical Center

Active, not recruiting

Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients (LADI)

Crohn Disease | Crohn Disease in Remission

Netherlands
Indiana University

Completed

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid Withdrawal

United States
Astellas Pharma Inc
FibroGen

Completed

A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia

Chronic Kidney Disease

Japan
Astellas Pharma Inc
FibroGen

Completed

A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia

Hemodialysis Chronic Kidney Disease Patients With Anemia

Japan
HIV Prevention Trials Network

Completed

The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP) (ADAPT)

HIV Infections

United States, South Africa, Thailand
Cryosa, Inc.

Active, not recruiting

Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA (ARCTIC-1)

Obstructive Sleep Apnea of Adult

Panama, Paraguay
Ultragenyx Pharmaceutical Inc
Novartis; Mereo BioPharma

Completed

Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density

Osteoporosis | Osteopenia

United States
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Prairie Education and Research Cooperative
American College of Phlebology

Terminated

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Deep Vein Thrombosis | Venous Thromboembolism | Coronary Artery Bypass Surgery
McGill University

Completed

A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Diabetes Mellitus, Type 2

Canada
Wake Forest University Health Sciences

Terminated

Fluid Resuscitation in Septic Shock Patients With BMI Elevation (FRISSBE)

Sepsis | Obesity | Septic Shock

United States
Hamad Medical Corporation
Qatar University

Completed

Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods

Infection, Bacterial

Qatar
Loyola University

Completed

Sub-dissociative Dose Ketamine Dosing Study

Acute Pain

United States
Chulalongkorn University

Completed

Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A

Severe Hemophilia A Without Inhibitor

Thailand
University of Alberta

Withdrawn

Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery (LSHT)

Neoplasms | Postoperative Complications | Hypothyroidism
Albert Einstein College of Medicine
University of Pittsburgh; Brigham and Women's Hospital; Wake Forest University... and other collaborators

Withdrawn

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage (IVHT4)

Intraventricular Hemorrhage of Prematurity

United States
Onconic Therapeutics Inc.

Completed

Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

Anti-Ulcer Agents

Korea, Republic of
Case Comprehensive Cancer Center

Terminated

Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

Gynecologic Malignancies

United States
Henry Ford Health System

Terminated

Will Hydroxychloroquine Impede or Prevent COVID-19 (WHIP COVID-19)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Coronavirus

United States
University of New Mexico
National Center for Research Resources (NCRR)

Completed

Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants

Preterm Infants

United States
Mayo Clinic

Completed

Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

Perioperative/Postoperative Complications

United States
Washington University School of Medicine
AOSpine North America

Completed

Tranexamic Acid Dosing in Adult Spinal Deformity Surgery

Adult Spinal Deformity

United States
SCRI Development Innovations, LLC
Bayer; Novartis

Completed

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Kidney Cancer

United States
University of Calgary
Alberta Health services

Completed

The Effect of Regular Naltrexone Dosing on Disordered Gamblers

Gambling

Canada
Biocad

Completed

An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis (BCD-085-7)

Moderate to Severe Plaque Psoriasis

Russian Federation
University of Puerto Rico
National Institute on Minority Health and Health Disparities (NIMHD); Genomas...

Completed

A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Cardiac Valvular Insufficiency | Coagulopathies

United States, Puerto Rico
Federico II University

Completed

Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism

Congenital Hypothyroidism
FibroGen

Completed

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

CKD Anemia in Dialysis Participants

China
China National Center for Cardiovascular Diseases

Completed

Genotype-guided Versus Standard for Warfarin Dosing

Atrial Fibrillation | Valvular Heart Disease

China
American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Pila Pharma
Biomapas

Completed

A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes

Diabetes Mellitus, Type 2 | Pharmacokinetics | Efficacy | Safety

Lithuania
Sanofi

Completed

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Microvascular Coronary Artery Disease

Germany
Massachusetts General Hospital

Withdrawn

Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia

Fibromyalgia

United States
Johns Hopkins University

Withdrawn

Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)

Pregnancy | HIV-1-infection
IBSA Institut Biochimique SA

Completed

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Hypothyroidism;Postablative

United States
University of Florida
Lacerta Therapeutics

Completed

Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease (AAV9-GAA_IM)

Pompe Disease

United States
Washington University School of Medicine
Brain & Behavior Research Foundation

Completed

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies (NARSAD)

Depressive Disorder, Major | Depressive Disorder, Treatment-Resistant

United States
Klinikum Lüdenscheid

Completed

Quality of Life After Interventional Thyroid Treatment (DSR)

Quality of Life | Thyroid; Deficiency

Germany
Clinical Evaluation Research Unit at Kingston General...

Completed

The Effect of Higher Protein Dosing in Critically Ill Patients (EFFORT)

Critical Illness | Malnutrition

United Kingdom, United States, Canada, Saudi Arabia, Malaysia, Argentina, Australia, Brazil, Greece, Hong Kong, India, Iran, Islamic Republic of, Japan, Mexico, Panama, Puerto Rico
AbbVie

Completed

A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants

Healthy Volunteers

United States
New York City Health and Hospitals Corporation

Completed

Weight-Based Torsemide Dosing in Subjects With Heart Failure

Heart Failure

United States
University of Utah
University of Colorado, Denver

Completed

Asprin Dosing Estimator in Healthy Adults

Aspirin Sensitivity

United States
University Hospital, Caen
Biogen

Completed

Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort (RELEVANT)

Multiple Sclerosis, Relapsing-Remitting

France
University of Louisville

Withdrawn

Reinforcement Learning for Warfarin Dosing

Clotting Disorder
University of Dundee

Completed

Appropriate Dosing to Optimise Personalised Cancer Treatments (ADOPT)

Ovarian Cancer | Lung Cancer, Non-small Cell | Melanoma Stage IV | Melanoma Stage III | Renal Cancer Stage III | Renal Cancer Stage IV

United Kingdom
German Breast Group
Novartis

Completed

Dose EScalation Induction of EvERolimus (Desiree)

Breast Cancer | Hormone Receptor Positive Tumor

Germany

Search clinical trials for: Levothyroxine Dosing

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations